再狭窄ofrestenosis;therestenosis是指成功介入治疗手术,受治疗冠脉局部损伤后“愈合”反应而造成局部血管腔的再次狭窄。
n. restenosis
抗骨桥蛋白抗体防治内皮剥脱术后血管狭窄的实验研究 (percutaneoustransluminalcoronaryangioplasty,PTCA)术后血管再狭窄(restenosis,RS)是一个过度的创伤愈合过程.平滑肌细胞的增殖和迁移、细胞外基质的异常积聚以及血管重塑是造成再狭窄的主要
基于766个网页-相关网页
...再狭窄 [gap=1525]ds】 sirolimus-eluting stent; coronary artery disease; intra-stent thrombosis; in-stent restenosis ...
基于24个网页-相关网页
3.5.7低分子肝素和MaxEPA预防冠脉扩张成形术后的再狭窄(EMPAR) 3.5.8长期应用血栓素A2受体阻滞剂对冠脉球囊扩张成形术后再狭窄和临床事件的影响(CARPORT研究)
基于12个网页-相关网页
支架内再狭窄 ISR ; in-stent restenosis ; restenosisin-stent
冠状动脉再狭窄 coronary restenosis ; restenosis ; CRS
血管再狭窄 restenosis ; vascular restenosis ; RS ; in-stent restenosis
后再狭窄 restenosis ; RS ; RAA ; restenosis after angioplasty
术后再狭窄 restenosis ; RS ; in-stent restenosis ; ISR
再狭窄率 binary restenosis ; restenosis ; in-stent restenosis ; ISR
支架再狭窄 in-stent restenosis ; stent-restenosis ; ISR
再狭窄试验 EUROCARE
后血管再狭窄 restenosis ; RS
Objective To construct a replication-defective recombinant adenovirus expressing β-galactosidase for providing a control vector in future study of gene therapy for restenosis, and of safety, feasibility, and efficiency of gene transfer mediated by adenovirus.
目的:构建表达β-半乳糖苷酶(β-gal)的重组腺病毒,以期为再狭窄的基因治疗研究提供一个对照载 体和为腺病毒介导的基因转移的安全性、可行性、转染效率的研究提供一有用的工具。
参考来源 - 重组β·2,447,543篇论文数据,部分数据来源于NoteExpress
血管成形术后发生再狭窄影响手术的远期疗效。
Restenosis after angioplasty influences the long dated surgical effect.
目的研究血管活性肽在血管再狭窄形成中的作用。
Objective To investigate the effects of several vasoactive peptides on the development of restenosis.
然而,支架也更容易再狭窄从而导致冠状动脉再次闭塞。
However, they are also more likely to lead to restenosis, a recurrence of artery clogging.
应用推荐